NCT00278330 2013-04-02
Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia
National Cancer Institute (NCI)
Phase 1 Completed
National Cancer Institute (NCI)
Virginia Commonwealth University